Researchers from Novosibirsk Institute of organic chemistry, together with colleagues from Tomsk company "Rioni" began work on a drug intended for the treatment of Parkinson's disease.
Experts have already managed to test on animals. The drug has shown itself remarkably, and now scientists are planning clinical trials. According to preliminary results, the compound obtained can cure a person from Parkinson's disease, if the pathology was able to identify at an early stage.
Today, experts are busy studying the toxic effects of drugs and the development of the plan clinical trials. All research team will need about one and a half years.
The novelty will be more secure than any of the existing tools for the treatment of Parkinson's disease. Note, today in Russia the disease is diagnosed at 200 thousand people. Worldwide, a number that exceeds 4 million. Drugs, completely save from Parkinson's disease, yet.